Company Name, Ticker, Competitors, else..

Replimune Group Inc (REPL)

Other Ticker:

Sector • Healthcare Industry • Biotechnology & Pharmaceuticals

Industry • Biotechnology & Pharmaceuticals

Sector • Healthcare

Replimune Group Inc

REPL's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

REPL Growth rates comparisons

Replimune Group Inc 's sales fell in III. Quarter 2022 from the same quarter a year ago.

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -4.45 %

• More on REPL's Growth

REPL's Valuation comparisons

Replimune Group Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 15.38 in trailing twelve-month period.

Company

-

PE TTM

Industry

-

PE TTM

Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.55.

• More on REPL's Valuation

Total Debt (Millions $)	28
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	-
Net Income/Employee (TTM) $	-
Receivable Turnover (TTM)	-
Tangible Book Value (Per Share $)	10.29

REPL's Valuation comparisons

Replimune Group Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 15.38 in trailing twelve-month period.

Company

-

PE TTM

Industry

-

PE TTM

Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.55.

Replimune Group Inc Price to Book Ratio is at 1.92 higher than Indusry Avg. of -0.02, and higher than S&P 500 Avg. of -0.01

• More on REPL's Valuation

• Market Capitalization (Millions $)	1,144
• Shares Outstanding (Millions)	58
• Employees	-
• Revenues (TTM) (Millions $)	-
• Net Income (TTM) (Millions $)	-157
• Cash Flow (TTM) (Millions $)	74
• Capital Exp. (TTM) (Millions $)	-3
• Total Debt (Millions $)	28
• Dividend TTM ($)	0 $
• Dividend Yield TTM (%)	-
• Revenue/Employee (TTM) $	-
• Net Income/Employee(TTM) $	-
• Receivable Turnover Ratio (TTM)	-
• Tangible Book Value (Per Share $)	10.29

• Market Capitalization (Millions $)	1,144
• Shares Outstanding (Millions)	58
• Employees	-
• Revenues (TTM) (Millions $)	-
• Net Income (TTM) (Millions $)	-157
• Cash Flow (TTM) (Millions $)	74
• Capital Exp. (TTM) (Millions $)	-3

	*Ratio*
• Capital Ratio (MRQ)	23.58
• Total Debt to Equity (MRQ)	0.05
• Tangible Leverage Ratio (MRQ)	0.14
• Asset Turnover Ratio (TTM)	-
• Inventory Turnover Ratio (TTM)	-

REPL's Profitability Comparisons

• More on REPL's Key Ratios


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar PEG's Profile Stock Price PEG's Financials Business Description Fundamentals Charts & Quotes PEG's News Suppliers PEG's Competitors Customers & Markets Economic Indicators PEG's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071